Astellas Pharma Inc. (4503) - Analysis

1,402 JPY

17

1.23%

Last update Jun 27, 3:24 PM JST

Market closed

Day range

1,402

1,384

1,404

Previous close

1,385

Open

1,391

Access this stock data via API

Astellas Pharma Inc.

1,402.00

17

1.23%

Analysis

Revenue estimate	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Mar 2026)	Next year(Mar 2027)
Number of Analysts	5	5	13	13
Avg. estimate	468.20B	476.23B	1.95T	2.03T
Low estimate	453.40B	463.20B	1.90T	1.84T
High estimate	487.32B	491.10B	2.01T	2.12T
Last year sales	473.12B	462.50B	789.62B	1.95T
Sales growth	-0.01	0.03	1.46	0.04

EPS trend	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Mar 2026)	Next year(Mar 2027)
Current estimate	0	0	0	0
7 days ago	0	0	0	0
30 days ago	0	0	0	0
60 days ago	0	0	0	0
90 days ago	0	0	0	0

EPS revisions	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Mar 2026)	Next year(Mar 2027)
Up last 7 days	0	0	0	0
Up last 30 days	0	0	0	0
Down last 7 days	0	0	0	0
Down last 30 days	0	0	0	0